ITCI
Victory Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,938
| Closed | -$1.57M | – | 2575 |
|
|
2025
Q1 | $1.57M | Sell |
11,938
-50,261
| -81% | -$6.63M | ﹤0.01% | 1599 |
|
|
2024
Q4 | $5.19M | Sell |
62,199
-1,543
| -2% | -$129K | 0.01% | 1258 |
|
|
2024
Q3 | $4.66M | Sell |
63,742
-4,397
| -6% | -$322K | ﹤0.01% | 1285 |
|
|
2024
Q2 | $4.67M | Buy |
68,139
+4,674
| +7% | +$320K | ﹤0.01% | 1258 |
|
|
2024
Q1 | $4.39M | Sell |
63,465
-2,491
| -4% | -$172K | ﹤0.01% | 1266 |
|
|
2023
Q4 | $4.72M | Sell |
65,956
-1,523
| -2% | -$109K | 0.01% | 1245 |
|
|
2023
Q3 | $3.51M | Sell |
67,479
-818
| -1% | -$42.6K | ﹤0.01% | 1273 |
|
|
2023
Q2 | $4.32M | Sell |
68,297
-1,234
| -2% | -$78.1K | ﹤0.01% | 1231 |
|
|
2023
Q1 | $3.77M | Sell |
69,531
-38,349
| -36% | -$2.08M | ﹤0.01% | 1254 |
|
|
2022
Q4 | $5.71M | Sell |
107,880
-187,515
| -63% | -$9.92M | 0.01% | 1178 |
|
|
2022
Q3 | $13.7M | Sell |
295,395
-839,455
| -74% | -$39.1M | 0.02% | 956 |
|
|
2022
Q2 | $64.8M | Buy |
1,134,850
+202,528
| +22% | +$11.6M | 0.07% | 364 |
|
|
2022
Q1 | $56.9M | Buy |
+932,322
| New | +$56.9M | 0.06% | 470 |
|